Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Metsera, Inc. (MTSR)

23.14
+0.40
+(1.76%)
At close: May 7 at 4:00:01 PM EDT
22.80
-0.34
(-1.47%)
Pre-Market: 5:02:30 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
Total Revenue
0
0
0
Operating Expense
134,314
134,314
30,606
Operating Income
-134,314
-134,314
-30,606
Net Non Operating Interest Income Expense
5,962
5,962
1,918
Other Income Expense
-90,113
-90,113
-18,518
Pretax Income
-218,465
-218,465
-47,206
Tax Provision
-9,338
-9,338
0
Net Income Common Stockholders
-209,127
-209,127
-47,206
Diluted NI Available to Com Stockholders
-209,127
-209,127
-47,206
Basic EPS
-2.03
--
-0.95
Diluted EPS
-2.03
--
-0.95
Basic Average Shares
103,035.18
--
49,944.66
Diluted Average Shares
103,035.18
--
49,944.66
Total Operating Income as Reported
-224,833
-224,833
-43,669
Total Expenses
134,314
134,314
30,606
Net Income from Continuing & Discontinued Operation
-209,127
-209,127
-47,206
Normalized Income
-122,870.84
-122,870.84
-34,140
Interest Income
6,185
6,185
1,918
Interest Expense
223
223
0
Net Interest Income
5,962
5,962
1,918
EBIT
-218,242
-218,242
-47,206
EBITDA
-218,228
-218,228
-47,204
Reconciled Depreciation
14
14
2
Net Income from Continuing Operation Net Minority Interest
-209,127
-209,127
-47,206
Total Unusual Items Excluding Goodwill
-90,113
-90,113
-13,066
Total Unusual Items
-90,113
-90,113
-13,066
Normalized EBITDA
-128,115
-128,115
-34,138
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
-3,856.84
-3,856.84
0
12/31/2023 - 1/31/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MAZE Maze Therapeutics, Inc.
9.49
+4.17%
 
GPCR Structure Therapeutics Inc.
26.60
+5.01%
 
AARD Aardvark Therapeutics, Inc.
10.63
+1.92%
 
CGON CG Oncology, Inc.
22.34
+2.95%
 
AKRO Akero Therapeutics, Inc.
42.79
+1.83%
 
LXEO Lexeo Therapeutics, Inc.
2.9900
-8.00%
 
SION Sionna Therapeutics, Inc.
12.88
+0.94%
 
BBIO BridgeBio Pharma, Inc.
35.82
-3.03%
 
ASND Ascendis Pharma A/S
160.99
-1.14%
 
JANX Janux Therapeutics, Inc.
25.70
+0.63%